$0.19
Virios Therapeutics is a biotechnology business based in the US. Virios Therapeutics shares (VIRI) are listed on the NASDAQ and all prices are listed in US Dollars. Virios Therapeutics employs 4 staff and has a market cap (total outstanding shares value) of 0.00.
Our top picks for where to buy Virios Therapeutics Llc stock
How to buy Virios Therapeutics stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – VIRI. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Virios Therapeutics stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Virios Therapeutics stock price (NASDAQ: VIRI)
Use our graph to track the performance of VIRI stocks over time.Virios Therapeutics shares at a glance
Latest market close | $0.18 |
---|---|
52-week range | $0.16 - $1.10 |
50-day moving average | $0.22 |
200-day moving average | $0.40 |
Wall St. target price | $1.40 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-0.23 |
Is it a good time to buy Virios Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Virios Therapeutics price performance over time
Historical closes compared with the close of $0.1846 from 2024-09-05
1 week (2024-08-30) | -4.85% |
---|---|
1 month (2024-08-06) | -4.99% |
3 months (2024-06-06) | -21.78% |
6 months (2024-03-06) | -50.11% |
1 year (2023-09-06) | -81.90% |
---|---|
2 years (2022-09-06) | -97.35% |
3 years (2021-09-03) | 5.68 |
5 years (2019-09-02) | N/A |
Virios Therapeutics financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -67.76% |
Return on equity TTM | -119.56% |
Profit margin | 0% |
Book value | $0.11 |
Market Capitalization | $5.4 million |
TTM: trailing 12 months
Virios Therapeutics share dividends
We're not expecting Virios Therapeutics to pay a dividend over the next 12 months.
You may also wish to consider:
- Gilead Sciences (GILD.US) (3.9% forward annual dividend yield)
Virios Therapeutics share price volatility
Over the last 12 months, Virios Therapeutics's shares have ranged in value from as little as $0.1557 up to $1.1. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Virios Therapeutics's is 1.597. This would suggest that Virios Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
To put Virios Therapeutics's beta into context you can compare it against those of similar companies.
- BioCryst Pharmaceuticals (BCRX.US): 1.879
- Gilead Sciences (GILD.US): 0.199
- Inovio Pharmaceuticals (INO.US): 0.894
Virios Therapeutics overview
Virios Therapeutics, Inc. , a development-stage biotechnology company, focuses on developing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It also develops IMC-2, a combination of valacyclovir and celecoxib for the treatment of managing the fatigue, sleep, attention, pain, autonomic function, and anxiety associated with long COVID. The company was formerly known as Innovative Med Concepts, LLC and changed its name to Virios Therapeutics, Inc. in July 2020. The company was founded in 2012 and is headquartered in Alpharetta, Georgia.
Frequently asked questions
What percentage of Virios Therapeutics is owned by insiders or institutions?Currently 6.738% of Virios Therapeutics shares are held by insiders and 6.116% by institutions. How many people work for Virios Therapeutics?
Latest data suggests 4 work at Virios Therapeutics. When does the fiscal year end for Virios Therapeutics?
Virios Therapeutics's fiscal year ends in December. Where is Virios Therapeutics based?
Virios Therapeutics's address is: 44 Milton Avenue, Alpharetta, GA, United States, 30009 What is Virios Therapeutics's ISIN number?
Virios Therapeutics's international securities identification number is: US92829J1043
More guides on Finder
-
Options profit calculator
Use this calculator to quickly see potential outcomes of your options trades.
-
Best paper trading platforms to practice trading with fake money [2024]
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
-
7 best day trading platforms of 2024
These are the best day trading platforms, according to Finder’s comprehensive analysis.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
Trading for beginners: 11 best trading platforms to get started
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
-
5 best international stock brokers to invest in foreign assets
Want to buy and sell international stocks? Here are the top brokers to help you trade global markets.
-
9 best discount brokers of 2024 for low-cost trading and investing
These are the best discount brokers of 2024 according to Finder’s comprehensive review.
-
10 best brokerage accounts for buying stocks, options and more in 2024
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
Ask a question